EZH2 and glioblastoma: Recently, Suvà ML and colleagues showed that pharmacologic inhibition of EZH2 in GBM spheres by 3-deazaneplanocin A (DZNep) at 5 μmol/L for 5 days resulted in a > 80% decrease in the clonogenic index.